Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Hemogenyx Pharmaceuticals launches Phase I AML trial for HG-CT-1 CAR-T therapy
Hemogenyx Pharmaceuticals plc (LSE: HEMO), a leading biopharmaceutical company, has taken a significant step forward in the fight…
January 5, 2025
Haleon increases stake in Chinese JV Tianjin TSKF Pharmaceutical to 88%
Haleon plc, a leading name in consumer healthcare, has successfully completed the acquisition of an additional 33% equity…
January 5, 2025
Hutchmed secures priority review in China for ORPATHYS and TAGRISSO combination therapy
Hutchmed (China) Limited has achieved a significant milestone with the acceptance of its New Drug Application (NDA) by…
January 5, 2025
HUTCHMED to sell non-core JV for $608m to focus on oncology
HUTCHMED (China) Limited has taken a bold step in streamlining its operations by divesting its 45% equity interest…
January 5, 2025
Wockhardt secures approval for Miqnaf: A breakthrough in pneumonia treatment
In a landmark decision addressing the global challenge of antibiotic resistance, the Indian drug regulator, Central Drugs Standard…
January 3, 2025
Neumora Therapeutics’ KOASTAL-1 study of navacaprant for MDD falls short on primary endpoint
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company specialising in neuroscience, has announced results from the KOASTAL-1…
January 2, 2025
Innovent Biologics and Roche partner to advance DLL3 antibody drug conjugate
Innovent Biologics, Inc., a biopharmaceutical company, has entered a strategic global licensing agreement with Roche to propel the…
January 2, 2025
Corcept Therapeutics submits FDA application for relacorilant to treat Cushing’s syndrome
Corcept Therapeutics Incorporated has taken a significant step in addressing the unmet needs of patients with hypercortisolism, commonly…
December 31, 2024
FDA approves Opdivo Qvantig, a new subcutaneous immunotherapy option for cancer treatment
In a significant advancement for oncology care, the U.S. Food and Drug Administration (FDA) has approved Opdivo Qvantig…
December 30, 2024
Axcelead DDP partners with Astellas for targeted protein degrader discovery
Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) has entered into a strategic service agreement with Astellas Pharma, Inc.,…
December 26, 2024